We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Delivers Final Blow to Generic Drugmakers Eyeing OxyContin Copycats
FDA Delivers Final Blow to Generic Drugmakers Eyeing OxyContin Copycats
April 16, 2013
FDA delivered a strong message in the fight on prescription drug abuse Tuesday, announcing it “will not accept or approve any [ANDAs] that rely upon the approval of original OxyContin.”